Chemotherapy, hormonal therapy, and steroid receptors in gynecologic cancer.
Blackledge
G
G
Cancer Research Campaign Clinical Trials Unit, University of Birmingham, UK.
Varma
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000378:metabolism; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000378:metabolism; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality; D011379:Prognosis; D011987:Receptors, Steroid / Q000032:analysis* / Q000187:drug effects; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality
D000970:Antineoplastic Agents; D006728:Hormones; D009944:Organoplatinum Compounds; D011987:Receptors, Steroid